Beacon Investment Advisory Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,315
| Closed | -$131K | – | 285 |
|
|
2023
Q1 | $131K | Hold |
11,315
| – | – | 0.01% | 274 |
|
|
2022
Q4 | $92.6K | Sell |
11,315
-3,292
| -23% | -$26.9K | ﹤0.01% | 275 |
|
|
2022
Q3 | $85K | Sell |
14,607
-997
| -6% | -$5.8K | ﹤0.01% | 271 |
|
|
2022
Q2 | $69K | Buy |
15,604
+270
| +2% | +$1.19K | ﹤0.01% | 278 |
|
|
2022
Q1 | $140K | Sell |
15,334
-479
| -3% | -$4.37K | 0.01% | 291 |
|
|
2021
Q4 | $324K | Buy |
15,813
+132
| +0.8% | +$2.71K | 0.01% | 253 |
|
|
2021
Q3 | $401K | Buy |
15,681
+1,990
| +15% | +$50.9K | 0.02% | 224 |
|
|
2021
Q2 | $479K | Buy |
13,691
+4,587
| +50% | +$160K | 0.02% | 211 |
|
|
2021
Q1 | $303K | Buy |
+9,104
| New | +$303K | 0.01% | 250 |
|